Skip to main content
. 2017 May 10;2017(5):CD006185. doi: 10.1002/14651858.CD006185.pub4

NCT01146587.

Trial name or title Comparative study of GangTrainer GT1, Lokomat and conventional physiotherapy (GALOP)
Methods RCT with 3 arms
Participants Inclusion criteria: first supratentorial stroke (ischaemic, haemorrhagic, or intracerebral haemorrhage) resulting in hemiparesis; interval from stroke 3 to 12 weeks; non‐ambulatory (FAC < 3); free sitting on bedside for 1 minute, with both feet on the floor and holding onto bedside by hands; Barthel Index 25 to 65
 Exclusion criteria: unstable cardiovascular system (in case of doubt, only after approval by an internist); manifested heart diseases like labile compensated cardiac insufficiency (NYHA III), angina pectoris, myocardial infarction 120 days before study onset, cardiomyopathy, severe cardiac arrhythmia, severe joint misalignment (severe constriction of movement for hip, knee, or ankle, or any combination of the 3: more than 20° fixed hip and knee extension deficit, or more than 20° fixed plantar flexion of the ankle); severe cognitive dysfunction that prevents comprehension of the aims of study; severe neurological or orthopaedic diseases (e.g. polio, Parkinson's disease) that massively affect mobility; deep vein thrombosis; severe osteoporosis; or malignant tumour disease
Interventions Group A: 30 minutes of treatment on the GangTrainer GT1 and 30 minutes of conventional physiotherapy every workday for 8 weeks
 Group B: 30 minutes of treatment on the Lokomat and 30 minutes of conventional physiotherapy every workday for 8 weeks
 Group C: 60 minutes of conventional physiotherapy every workday for 8 weeks
Outcomes Primary outcomes: FAC, modified Emory Functional Ambulation
Secondary outcomes: Barthel Index, 10‐metre walk test, 6‐minute walk test on the floor, Medical Research Council, Rivermead Visual Gait Assessment, EuroQol‐5 Dimensions (EQ‐5D)
Starting date August 2010
Contact information Contact: Andreas Waldner, MD; +39 0471 471 471; waldner.andreas@villamelitta.it
 Contact: Christopher Tomelleri, MSc; +39 0471 471 471; christopher.tomelleri@villamelitta.it
Notes Estimated enrolment: 120
 Estimated study completion date: August 2013
 Estimated primary completion date: August 2013 (final data collection date for primary outcome measure)